Variants of uncertain significance in BRCA testing: evaluation of surgical decisions, risk perception, and cancer distress

JO Culver, CD Brinkerhoff, J Clague, K Yang… - Clinical …, 2013 - Wiley Online Library
Studies suggest that patients carrying a BRCA variant of uncertain significance (VUS) may
have lingering confusion concerning results interpretation. Counseling for uninformative …

Screening BRCA1 and BRCA2 unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing …

C Bonnet, S Krieger, M Vezain, A Rousselin… - Journal of medical …, 2008 - jmg.bmj.com
Background: Many unclassified variants (UV) of BRCA1 or BRCA2 may have an effect on
pre-mRNA splicing. Patient blood samples suitable for RNA extraction are not always …

Managing the ethical challenges of next-generation sequencing in genomic medicine

AJ Clarke - British Medical Bulletin, 2014 - academic.oup.com
Introduction Next-generation sequencing (NGS) is transforming the conduct of genetic
research and diagnostic investigation. This creates new challenges as it generates …

Calibration of multiple in silico tools for predicting pathogenicity of mismatch repair gene missense substitutions

BA Thompson, MS Greenblatt, MP Vallee… - Human …, 2013 - Wiley Online Library
Classification of rare missense substitutions observed during genetic testing for patient
management is a considerable problem in clinical genetics. The Bayesian integrated …

Prediction and assessment of splicing alterations: implications for clinical testing

AB Spurdle, FJ Couch, FBL Hogervorst… - Human …, 2008 - Wiley Online Library
Sequence variants that may result in splicing alterations are a particular class of inherited
variants for which consequences can be more readily assessed, using a combination of …

Prospective study of cancer genetic variants: variation in rate of reclassification by ancestry

TP Slavin, LR Van Tongeren… - JNCI: Journal of the …, 2018 - academic.oup.com
Background In germline genetic testing, variants from understudied ancestries have been
disproportionately classified as being of uncertain significance. We hypothesized that the …

Clinical risk management of breast, ovarian, pancreatic, and prostatic cancers for BRCA1/2 variant carriers in Japan

A Ueki, R Yoshida, T Kosaka… - Journal of Human …, 2023 - nature.com
Opportunities for genetic counseling and germline BRCA1/2 (BRCA) testing are increasing
in Japan owing to cancer genomic profiling testing and companion diagnostics being …

[HTML][HTML] Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: a WECARE study report

JL Bernstein, DC Thomas, RE Shore, M Robson… - European Journal of …, 2013 - Elsevier
Background Women with germline BRCA1 or BRCA2 (BRCA1/BRCA2) mutations are at
very high risk of developing breast cancer, including asynchronous contralateral breast …

Functional Assays for Classification of BRCA2 Variants of Uncertain Significance

DJ Farrugia, MK Agarwal, VS Pankratz… - Cancer research, 2008 - AACR
The assessment of the influence of many rare BRCA2 missense mutations on cancer risk
has proved difficult. A multifactorial likelihood model that predicts the odds of cancer …

High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients

JD Fackenthal, J Zhang, B Zhang… - … journal of cancer, 2012 - Wiley Online Library
Inherited mutations in the BRCA1 and BRCA2 genes are the strongest genetic predictors of
breast cancer and are the primary causes of familial breast/ovarian cancer syndrome. The …